Prelude Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.24M | Buy |
15,000
+986
| +7% | +$81.8K | 0.12% | 210 |
|
2025
Q1 | $1.14M | Buy |
+14,014
| New | +$1.14M | 0.09% | 227 |
|
2024
Q4 | – | Sell |
-4,130
| Closed | -$408K | – | 1475 |
|
2024
Q3 | $408K | Buy |
+4,130
| New | +$408K | 0.02% | 632 |
|
2024
Q1 | – | Sell |
-3,440
| Closed | -$307K | – | 1436 |
|
2023
Q4 | $307K | Buy |
3,440
+294
| +9% | +$26.3K | 0.02% | 625 |
|
2023
Q3 | $230K | Buy |
+3,146
| New | +$230K | 0.02% | 693 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 1526 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 1808 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1860 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 1972 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 1966 |
|
2021
Q3 | – | Sell |
-9,797
| Closed | -$1.33M | – | 1755 |
|
2021
Q2 | $1.33M | Buy |
+9,797
| New | +$1.33M | 0.04% | 353 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 1427 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1622 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1908 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1748 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1630 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1812 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1634 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1768 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1798 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1786 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1716 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 1695 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1585 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1616 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1808 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 1799 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 1480 |
|
2015
Q4 | – | Hold |
0
| – | – | – | 1629 |
|
2015
Q2 | – | Sell |
-6,300
| Closed | -$474K | – | 1986 |
|
2015
Q1 | $474K | Buy |
+6,300
| New | +$474K | 0.07% | 346 |
|